01/06/2025
4:43 PM | Karunatilake Chulani (Reporting)
Werewolf Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
4:44 PM | Isaacs Randi (Reporting)
Werewolf Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
4:44 PM | Trost Timothy W. (Reporting)
Werewolf Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
4:51 PM | Lubman Ellen (Reporting)
Werewolf Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
4:41 PM | HICKLIN DANIEL J (Reporting)
Werewolf Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
3:04 PM | PFM Health Sciences, LP (Filed by)
Werewolf Therapeutics (Subject)
| Form SC 13G/A | |
11/14/2024
10:54 AM | BANK OF AMERICA CORP /DE/ (Filed by)
Werewolf Therapeutics (Subject)
| Form SC 13G/A | |
11/13/2024
3:30 PM | Rubric Capital Management LP (Filed by)
Werewolf Therapeutics (Subject)
| Form SC 13G/A | |
11/12/2024
8:37 AM | Adage Capital Management, L.P. (Filed by)
Werewolf Therapeutics (Subject)
| Form SC 13G/A | |
11/07/2024
8:06 AM | Werewolf Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2024
8:09 AM | Werewolf Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
Get the Latest News and Ratings for HOWL and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Werewolf Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
08/08/2024
6:21 AM | Werewolf Therapeutics (Filer)
| Form S-8 POS | |
08/08/2024
6:07 AM | Werewolf Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
6:12 AM | Werewolf Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/25/2024
6:07 AM | Werewolf Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/03/2024
6:56 AM | Werewolf Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/28/2024
3:27 PM | Werewolf Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/24/2024
6:44 PM | Lazarus Alon (Reporting)
Werewolf Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
6:45 PM | EVNIN LUKE (Reporting)
Werewolf Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
6:45 PM | Sherman Michael A. (Reporting)
Werewolf Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
6:46 PM | Chatterjee Meeta (Reporting)
Werewolf Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
6:48 PM | Atkins Michael B. (Reporting)
Werewolf Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
6:49 PM | Morrison Briggs (Reporting)
Werewolf Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
6:52 PM | DiRocco Derek (Reporting)
Werewolf Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
6:56 PM | Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund II, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Werewolf Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
3:52 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by)
Werewolf Therapeutics (Subject)
| Form SC 13D/A | |
05/03/2024
6:05 AM | Werewolf Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/03/2024
6:10 AM | Werewolf Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/12/2024
6:16 AM | Werewolf Therapeutics (Filer)
| Form DEF 14A | |
04/12/2024
6:17 AM | Werewolf Therapeutics (Filer)
| Form DEFA14A | |
04/12/2024
6:18 AM | Werewolf Therapeutics (Filer)
| Form ARS | |
03/07/2024
6:22 AM | Werewolf Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/07/2024
6:11 AM | Werewolf Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/07/2024
6:15 AM | Werewolf Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2024
4:17 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by)
Werewolf Therapeutics (Subject)
| Form SC 13D/A | |
02/13/2024
5:58 PM | BANK OF AMERICA CORP /DE/ (Filed by)
Werewolf Therapeutics (Subject)
| Form SC 13G | |
02/12/2024
5:06 AM | Rubric Capital Management LP (Filed by)
Werewolf Therapeutics (Subject)
| Form SC 13G/A | |
02/09/2024
3:39 PM | Werewolf Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/09/2024
3:35 PM | Werewolf Therapeutics (Filer)
| Form 424B5 | |
